Skip to content
BioArra logo — Pioneering U.S. serum-based solutions to advance cellular sc...

BioArra

Pioneering U.S. serum-based solutions to advance cellular science research and production.

Founded 2008 United States United States 11 employees Biotechnology, Food and Beverage +2

General Information

Company Name BioArra
Founded Year 2008
Location United States United States
Employees 11
Industries Biotechnology, Food and Beverage, Life Sciences +1
Social

BounceWatch is an independent company data service, not affiliated with BioArra. To contact BioArra, visit bioarra.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioArra compare?

A PDF of BioArra and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioArra soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioArra

BioArra is a pioneering company in the United States, specializing in serum-based solutions to advance cellular science research and production. Since its establishment in 2008, BioArra has positioned itself as a leading producer of exceptional quality serum. Operating from various USDA approved locations, the company focuses on the production of semi-processed serum to cater to the needs of customers in Research and Development, Pharmaceutical, and Biotechnology industries both domestically and internationally. With a strong presence in the Biotechnology, Food and Beverage, Life Sciences, and Manufacturing industries, BioArra has established itself as a key player in the market. As of the latest available information, there have been no reported recent investments or disclosed investors in BioArra. This signifies a potential opportunity for venture capitalists seeking to invest in a renowned company within the biotechnology sector.

Business keywords: serum-based solutions, cellular science, pharmaceutical industry, USDA approved, biotech industry, serum production, US origin products

No funding data available for BioArra yet.

BioArra Alternatives & Competitors

View All Alternatives
BioArra vs
QbDVision
QbDVision United States

QbDVision is the leading Digital CMC Platform for pharmaceutical and biotech manufacturing.

Series A
52 employees
BioArra vs

Empowering the Biotech Revolution - Providing Innovative Reagents for the Next Generation of Pharmac...

Seed
1 employees
Biotechnology, Food and Beverage
BioArra vs
Prolific Machines
Prolific Machines United States

Illuminating biology's limitless potential

Series B
65 employees
Biotechnology, Health Care

FAQ About BioArra

Pioneering U.S. serum-based solutions to advance cellular science research and production.
BioArra was founded in 2008.
BioArra is headquartered in United States.
BioArra operates in Biotechnology, Food and Beverage, Life Sciences and Manufacturing. Its work centres on serum-based solutions, cellular science, pharmaceutical industry and USDA approved.
BioArra has approximately 11 employees.
Top alternatives and competitors to BioArra include QbDVision, Tiamat Sciences Corp., Prolific Machines, MBL International Corporation, R.L. Schreiber, Inc. Flavor Purveyors. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioArra and QbDVision are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioArra, https://bouncewatch.com/company/bioarra, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout